SEER Stat Fact Sheets: Testis Cancer
Statistics at a GlanceShow More
At a Glance
- Estimated New Cases in 2013 7,920
- Estimated Deaths in 2013 370
Lifetime Risk: Lifetime risk is the probability of developing or dying from a disease in the course of one's lifespan. Based on the most recent data, approximately 0.4 percent of men will be diagnosed with testis cancer at some point during their lifetime.
Prevalence of this cancer: There are an estimated 221,020 men currently living with testis cancer in the United States.
Survival StatisticsShow More
How Many People Survive 5 Years Or More after Being Diagnosed with Testis Cancer?
Relative survival statistics compare the survival of patients diagnosed with cancer with the survival of people in the general population who are the same age, race, and sex and who have not been diagnosed with cancer. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.
Based on data from SEER 18 2003-2009. Gray figures represent those who have died from testis cancer. Green figures represent those who have survived 5 years or more.
Survival by Stage
Cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. In general, if the cancer is found only in the part of the body where it started it is localized (sometimes referred to as stage 1). If it has spread to a different part of the body, the stage is regional or distant. The earlier testis cancer is caught, the better chance a person has of surviving five years after being diagnosed. For testis cancer, 68.9% are diagnosed at the local stage. The 5-year survival for localized testis cancer is 99.1%.
- Localized (69%)
Confined to Primary Site
- Regional (18%)
Spread to Regional Lymph Nodes
- Distant (12%)
Cancer Has Metastasized
- Unknown (1%)
SEER 18 2003-2009, All Races, Males by SEER Summary Stage 2000
Number of New Cases and DeathsShow More
How Common Is This Cancer?
Compared to other cancers, testis cancer is rare.
|Common Types of Cancer||Estimated New
|3.||Lung and Bronchus Cancer||228,190||159,480|
|4.||Colon and Rectum Cancer||142,820||50,830|
|5.||Melanoma of the Skin||76,690||9,480|
|8.||Kidney and Renal Pelvis Cancer||65,150||13,680|
Testis cancer represents 0.5% of all new cancer cases in the U.S.
In 2013, it is estimated that there will be 7,920 new cases of testis cancer and an estimated 370 people will die of this disease.
Who Gets This Cancer?
Testicular cancer is most common in young adults.
Testis cancer rates are highest in people aged 20-34 years.
SEER 18 2006-2010, All Races, Males
- All RacesSex-Specific Cancer
- Asian /
- American Indian /
SEER 18 2006-2010, Age-Adjusted
Who Dies From This Cancer?
Testis cancer deaths are highest in people aged 20-34 years.
U.S. 2006-2010, All Races, Males
- All RacesSex-Specific Cancer
- Asian /
- Not Shown, <16 casesAmerican Indian /
U.S. 2006-2010, Age-Adjusted
Trends in RatesShow More
Changes Over Time
Keeping track of the number of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.
Using statistical models for analysis, rates for new testis cancer cases have been rising on average 0.9% each year over the last 10 years. Death rates have been stable over the same period. 5-year survival trends are shown below the figure.
|5-Year Relative Survival||80.0%||89.6%||92.5%||94.8%||94.8%||94.8%||96.6%||96.8%|
SEER 9 Incidence & U.S. Mortality 1975-2010, All Races, Males
More About This CancerShow More
Cancer and the Testis
Testicularcancer forms in tissues of one or both testicles. Most testicular cancers begin in germ cells (cells that make sperm) and are called testicular germ cell tumors.
Here are some resources for learning more about testicular cancer.
- More about risk factors for testicular cancer
- More about symptoms and diagnosis of testicular cancer
- More about treatment options for testicular cancer
- More about clinical trials
- More about cancer prevention
All statistics in this report are based on statistics from SEER and the Centers for Disease Control's National Center for Health Statistics. Most can be found within:
Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.
SEER Cancer Statistics Factsheets: Testis Cancer. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/testis.html
This factsheet focuses on population statistics that are based on the US population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse the SEER Cancer Statistics Review. To see statistics for a specific state, go to the State Cancer Profiles.
The statistics presented in this factsheet are based on the most recent data available, most of which can be found in the SEER Cancer Statistics Review. In some cases, different year spans may be used. Estimates for the current year are based on past data.
Cancer is a complex topic. There is a wide range of information available. This factsheet does not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although it provides links to information in many of these areas.